Brinckerhoff and Best Quoted on Tafas v. Doll
March 27, 2009
Life Sciences Law & Industry Report
Foley Partner and vice-chair of the Chemical & Pharmaceutical Practice Courtenay Brinckerhoff and Partner George Best were quoted in an article titled “Federal Circuit’s Tafas Decision Could Affect Life Sciences Patents Adversely, Experts Say” in the March 27, 2009 issue of BNA’s Life Sciences Law & Industry Report.
Reproduced with permission from BNA’s Life Sciences Law & Industry Report, by The Bureau of National Affairs, Inc. http://www.bna.com.
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.